X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 800 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 301-325 of 800 matching filings.

Per page
25
Current page
13
4

FORM 4

Filing date
15 Feb 2023
Reporting date
13 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90199

AMENDMENT NO. 3

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90199

SCHEDULE 13G/A, AMENDMENT #2

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90199

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90199

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90199

AMENDMENT NO. 4 TO THE SCHEDULE 13G

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-269335

S-8

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90199

X4 PHARMACEUTICALS, INC.

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90199

GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Filing date
20 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249544

424B5

Filing date
09 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249544

424B5

Filing date
07 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2022
Reporting date
07 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2022
Reporting date
07 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2022
Reporting date
07 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2022
Reporting date
07 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Nov 2022
Reporting date
03 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Nov 2022
Reporting date
03 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .